Handheld Electro-Shockers Pose Risk for Interaction With Implantable Cardiac Devices
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 9, 2025 -- When applied to cardiac implantable electronic devices (CIEDs), commercially available handheld electro-shockers pose a relevant risk for interaction, according to a study published online April 9 in HeartRhythm.
Felix K. Wegner, M.D., from University Hospital Munster in Germany, and colleagues examined the effects of handheld electro-shockers on CIEDs. Six pacemakers (PMs) and 10 implantable cardioverter-defibrillators (ICDs) from different manufacturers were implanted in a subcutaneous and submuscular location in an isolated section of a porcine chest and were connected to an interactive heart simulator. Three electro-shockers with varying voltage (PowerMax [500,000 V]; Electric Guard [250,000 V]; Bikenda [<50,000 V]) were applied to the porcine chest successively.
The researchers found that during testing, there was no damage to any of the PMs or ICDs. The highest rate of interaction subcutaneously was documented with the PowerMax electro-shocker; all 16 devices inhibited stimulation during electro-shock application and six of 10 ICDs stored a ventricular high-rate episode. Inhibition of stimulation was seen in 10 of 16 devices with application of the Electric Guard electro-shocker, while one of the ICDs had a stored ventricular high-rate episode. The lowest rate of oversensing was seen with the Bikenda electro-shocker, with inhibition of stimulation in two devices; none of the 10 ICDs had storage of a ventricular high-rate episode. No relevant difference was seen between subcutaneous and submuscular placement of the device.
"The risk of interaction is primarily dependent on applied voltage, but resulting changes in cardiac device behavior differ according to the respective manufacturer," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Risk of Poor Cardiovascular Outcomes Up in Aging Patients With Down Syndrome
THURSDAY, May 15, 2025 -- Individuals with Down syndrome are at increased risk of poor cardiovascular outcomes, according to a study published online May 7 in the Journal of...
CVD Mortality Higher in Women Than Men With Immune-Mediated Inflammatory Diseases
TUESDAY, May 13, 2025 -- For patients with immune-mediated inflammatory diseases (IMID), cardiovascular disease (CVD) mortality decreased from 1999 to 2020, but sex disparities...
Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24
FRIDAY, May 9, 2025 -- Adolescent hyperglycemia and worsening insulin resistance (IR) are associated with an increased risk for worsening structural and functional cardiac damage...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.